Ledger.Open graph →
SEC Form D · filed May 15, 2025

Crosslink Therapeutics Inc

Offering
$8.0M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Rodolfo D. Chaparro · Boston, MADirectorRonald D. Seidel, Iii · Boston, MAExec · DirectorCameron D. Gallagher · Boston, MADirectorLou D. Tartaglia · Boston, MADirectorAndrew D. King · Boston, MAExecRonald D. Seidel, Iii · Boston, MAExec · DirectorCameron D. Gallagher · Boston, MADirectorLou D. Tartaglia · Boston, MADirectorRodolfo D. Chaparro · Boston, MADirectorAndrew D. King · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗